Entera Bio Ltd.
ENTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,541 | -$8,889 | -$13,071 | -$12,187 |
| Dep. & Amort. | $46 | $56 | $64 | $53 |
| Deferred Tax | $14 | $29 | $174 | -$217 |
| Stock-Based Comp. | $2,556 | $1,689 | $0 | $1,861 |
| Change in WC | $112 | -$195 | -$1,835 | $1,409 |
| Other Non-Cash | -$5 | $0 | $2,169 | $18 |
| Operating Cash Flow | -$6,818 | -$7,310 | -$12,499 | -$9,063 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$17 | -$47 | -$17 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$55 | $0 |
| Investing Cash Flow | -$3 | -$17 | -$102 | -$17 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,960 | $6,616 | $13 | $21,805 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $516 | -$580 | $0 | $3,576 |
| Financing Cash Flow | $4,476 | $6,036 | $13 | $25,381 |
| Forex Effect | $0 | $0 | $5 | $0 |
| Net Chg. in Cash | -$2,345 | -$1,291 | -$12,583 | $16,301 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,085 | $12,376 | $24,892 | $8,663 |
| End Cash | $8,740 | $11,085 | $12,309 | $24,964 |
| Free Cash Flow | -$6,821 | -$7,327 | -$12,546 | -$9,080 |